Testing effectiveness (Phase 2)Not Yet RecruitingNCT07815197
What this trial is testing
Sacituzumab Tirumotecan as Second-Line Treatment for Penile Cancer
Who this might be right for
Penile Squamous Cell CarcinomaMetastatic Penile Squamous Cell Carcinoma
Latin American Cooperative Oncology Group 37